Zacks Research Predicts Unum Group's Q3 Earnings (NYSE:UNM)

Key Points

• Zacks Research has downgraded Unum Group's Q3 2025 earnings per share estimate from $2.32 to $2.18, while the full-year earnings estimate is currently $9.14.
• Unum Group recently announced a quarterly dividend increase to $0.46 per share, with a yield of 2.6%, reflecting a positive change from their previous dividend.
• Analysts have a consensus "Moderate Buy" rating on Unum Group, with a target price average of $91.62, while various analysts have adjusted price targets between $85.00 to $100.00.

Unum Group (NYSE:UNM - Free Report) - Equities researchers at Zacks Research dropped their Q3 2025 earnings per share estimates for Unum Group in a research report issued to clients and investors on Tuesday, August 12th. Zacks Research analyst D. Chatterjee now forecasts that the financial services provider will earn $2.18 per share for the quarter, down from their prior estimate of $2.32. The consensus estimate for Unum Group's current full-year earnings is $9.14 per share. Zacks Research also issued estimates for Unum Group's Q4 2025 earnings at $2.21 EPS, FY2025 earnings at $8.50 EPS, Q1 2026 earnings at $2.18 EPS, Q2 2026 earnings at $2.27 EPS, Q3 2026 earnings at $2.47 EPS, Q4 2026 earnings at $2.27 EPS, FY2026 earnings at $9.19 EPS, Q2 2027 earnings at $2.47 EPS and FY2027 earnings at $10.11 EPS.

Other equities analysts also recently issued research reports about the company. Wells Fargo & Company cut their target price on Unum Group from $105.00 to $100.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. Piper Sandler raised their target price on shares of Unum Group from $88.00 to $92.00 and gave the stock an "overweight" rating in a report on Thursday, July 3rd. Morgan Stanley lifted their price target on shares of Unum Group from $83.00 to $85.00 and gave the stock an "equal weight" rating in a research note on Monday, July 14th. JPMorgan Chase & Co. raised their price objective on shares of Unum Group from $87.00 to $96.00 and gave the stock a "neutral" rating in a research note on Tuesday, July 8th. Finally, Barclays set a $96.00 target price on Unum Group and gave the company an "overweight" rating in a research report on Monday, July 7th. Five analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Unum Group has an average rating of "Moderate Buy" and a consensus price target of $91.62.

Unum Group Stock Performance

Unum Group stock opened at $70.33 on Wednesday. The company has a quick ratio of 0.30, a current ratio of 0.30 and a debt-to-equity ratio of 0.31. Unum Group has a twelve month low of $52.71 and a twelve month high of $84.48. The company's 50-day moving average price is $78.09 and its 200-day moving average price is $78.25. The company has a market cap of $11.98 billion, a PE ratio of 8.41, a price-to-earnings-growth ratio of 1.12 and a beta of 0.40.

Unum Group (NYSE:UNM - Get Free Report) last posted its earnings results on Tuesday, July 29th. The financial services provider reported $2.07 earnings per share for the quarter, missing analysts' consensus estimates of $2.23 by ($0.16). The business had revenue of $3.36 billion during the quarter, compared to analysts' expectations of $3.35 billion. Unum Group had a net margin of 11.77% and a return on equity of 13.44%. The company's revenue for the quarter was up 4.0% compared to the same quarter last year. During the same period last year, the business posted $2.16 earnings per share.

Unum Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 25th will be issued a dividend of $0.46 per share. This represents a $1.84 annualized dividend and a yield of 2.6%. The ex-dividend date is Friday, July 25th. This is a positive change from Unum Group's previous quarterly dividend of $0.42. Unum Group's dividend payout ratio (DPR) is currently 22.01%.

Institutional Trading of Unum Group

A number of hedge funds have recently bought and sold shares of the stock. Vermillion & White Wealth Management Group LLC raised its stake in shares of Unum Group by 44.0% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 537 shares of the financial services provider's stock worth $43,000 after acquiring an additional 164 shares in the last quarter. Choreo LLC boosted its position in shares of Unum Group by 17.4% in the 2nd quarter. Choreo LLC now owns 7,766 shares of the financial services provider's stock worth $627,000 after purchasing an additional 1,152 shares in the last quarter. Boston Partners grew its stake in Unum Group by 46.6% during the 2nd quarter. Boston Partners now owns 121,139 shares of the financial services provider's stock worth $9,781,000 after buying an additional 38,505 shares during the last quarter. J.W. Cole Advisors Inc. increased its position in Unum Group by 8.2% during the 2nd quarter. J.W. Cole Advisors Inc. now owns 6,404 shares of the financial services provider's stock valued at $517,000 after buying an additional 485 shares in the last quarter. Finally, Manchester Capital Management LLC raised its stake in Unum Group by 240.5% in the second quarter. Manchester Capital Management LLC now owns 3,507 shares of the financial services provider's stock valued at $283,000 after buying an additional 2,477 shares during the last quarter. Hedge funds and other institutional investors own 86.57% of the company's stock.

About Unum Group

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.